kevin b. jones, md charles searby, bs gail kurriger, bs james martin, phd peter j. roughley, phd
DESCRIPTION
Osteochondromagenesis: Loss of heterozygosity modeled via Cre-mediated inversion of the second exon of Ext1 in chondrocytes. Department of Orthopaedics and Rehabilitation University of Iowa Hospitals & Clinics. Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/1.jpg)
Kevin B. Jones, MDCharles Searby, BSGail Kurriger, BS
James Martin, PhDPeter J. Roughley, PhD
Jose A. Morcuende, MD, PhDJoseph A. Buckwalter, MD, MS
Val C. Sheffield, MD, PhD
Department ofOrthopaedics and RehabilitationUniversity of IowaHospitals & Clinics
Osteochondromagenesis: Loss of heterozygosity modeled via Cre-mediated inversion
of the second exon of Ext1 in chondrocytes
Connective Tissue Oncology Society
London, UK
Friday, 14 November 2008
![Page 2: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/2.jpg)
Human EXT1: What is known clinically. . .
Hereditary Multiple Exostosis• Autosomal dominant inheritance
• Shortened long bones
• Multiple osteochondromas
• Homozygosity lethal
![Page 3: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/3.jpg)
![Page 4: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/4.jpg)
EXT1 & EXT2: Tumor Supressor Genes?
• Loss of heterozygosity in chondrocytes of cartilage cap of HME osteochondromas
• Both alleles somatically mutated in some solitary osteochondromas
Raskind et al. 1995; Bovee et al. 1999; Hecht et al. 1995 and 1997.
![Page 5: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/5.jpg)
![Page 6: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/6.jpg)
Ext1 Knock-Out Mice by Lin et al. 2000
Mouse Ext1 has 99% Homology to Human EXT1
PROBLEMS:• Homozygous Ext1-knock-out mice do not
survive to birth• Heterozygous Ext1-knock-out mice very
rarely form osteochondromas
Simlar with Ext2 knock-out mice, Sitckens et al. 2005.
![Page 7: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/7.jpg)
Of Mice and Men
![Page 8: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/8.jpg)
Of Mice and Men
![Page 9: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/9.jpg)
~60 kg Human flesh
~30gMouse flesh
~2000X the number of cells
![Page 10: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/10.jpg)
Haploinsufficiency
or
Loss of Heterozygosity?
![Page 11: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/11.jpg)
Methods
![Page 12: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/12.jpg)
CRE
loxP loxPLoxP LoxP
Cre
Routine or cis orientation of loxP sites results in fragment excision
![Page 13: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/13.jpg)
trans orientation of loxP sites results in reversible fragment inversion
CRE
Pxol loxP
CODING SEQUENCE
ECNEUQES GNIDOC
LoxP PxoL
Cre
CODING SEQUENCE
ECNEUQES GNIDOC
![Page 14: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/14.jpg)
You do the math. . .
• Cre-mediated inversion yields 40% reverse orientation per trans-floxed allele
• Homozygosity for trans-floxed alleles should yield 40% loss of total copies of functional gene across tissue– 20% of cells will remain unaffected and fwd/fwd
– 20% of cells will end up fwd/fwd after inversion
– 40% of cells will end up fwd/rev after inversion
– 20% of cells will end up rev/rev after inversion
![Page 15: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/15.jpg)
Targeting Construct
Intron 1 loxP exon 2 loxP neo loxP intron 2 exon 3
• Exon 2 contains two of the very few disease-causing missense mutations at highly conserved amino acid residues 339 and 340.
• Exon 2 inversion not only disrupts the sequence, but introduces a stop codon in the reading frame
![Page 16: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/16.jpg)
Cre-Recombinase Driver
• Doxycycline-inducible
Collagen type II promoter-Cre
• Doxycycline adminstered via maternal drinking water during second week of life
Gover and Roughley et al., 2006
![Page 17: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/17.jpg)
Results
![Page 18: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/18.jpg)
PCR Testing with Multiple Primers
Intron 1 loxP exon 2 loxP neo loxP intron 2 exon 3
• All permutations of flipping were present in every cartilage containing tissue.
![Page 19: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/19.jpg)
exon 2 neo
reversed exon 2 neo
reversed reversed neo exon 2
excised neo
excised neo
reversed exon 2
exon 2
excised neo
reversed neo exon 2
excised neo
![Page 20: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/20.jpg)
Effects of Cre-mediated inversion
RT-PCR demonstrated the expected 40% reduction in Ext1 transcripts across homozygous tissue exposed to Cre
![Page 21: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/21.jpg)
Phenotype:Osteochondromas?
![Page 22: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/22.jpg)
Distal femur physis6 week old Ext1 fl/fl
with doxy-col2-Cre
![Page 23: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/23.jpg)
![Page 24: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/24.jpg)
Proximal tibia6 week old Ext1 fl/fl
with doxy-col2-Cre
![Page 25: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/25.jpg)
![Page 26: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/26.jpg)
Genotype_____________________________________________
fl/fl+doxy-col2a1-Cre 12/12
fl/fl without Cre 0/5
wt/fl+doxy-col2a1-Cre 0/7
wt/fl without Cre 0/1
wt/wt without Cre 0/8
_______________________________
# of mice with osteochondromas/ # of mice over 6 weeks old
![Page 27: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/27.jpg)
Comparison
Traditional Knockout
• 50% tissue reduction in Ext1 alleles
• Very rare biallelic loss
• Osteochondromas very rare
Trans-floxed Conditional Knockout
• 40% tissue reduction in Ext1 alleles
• 20% biallelic loss
• Osteochondromas rampant
![Page 28: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/28.jpg)
Discussion
Loss of heterozygosity is the mechanism of
osteochondromagenesis in the setting of hereditary multiple exostoses
![Page 29: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/29.jpg)
Hypothesis
Disruption of both Ext1 alleles in a physeal
chondrocyte is sufficient to form an osteochondroma
![Page 30: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/30.jpg)
Alternate Hypothesis
Disruption of both Ext1 alleles in some physeal
chondrocytes is sufficient to derange signals and form osteochondromas
![Page 31: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/31.jpg)
Hypothesis vs. Alternate Hypothesis
Are osteochondromas
clonal (at least consistent) for
reverse orientation of exon 2?
On-going work with laser capture micro-dissection and in situ hybridization
![Page 32: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/32.jpg)
Conclusion
Osteochondromageneis resulted from low-prevalence biallelic disruption of Ext1 in
chondrocytes, modeling loss of heterozygosity with a unique twist on the
standard conditional knock-out
![Page 33: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/33.jpg)
Project Funding Support
• OREF Resident Research Award 2003
• Department of Orthopaedics and Rehabilitation, University of Iowa
• Val C. Sheffield Genetics Laboratory
Department ofOrthopaedics and RehabilitationUniversity of IowaHospitals & Clinics
![Page 34: Kevin B. Jones, MD Charles Searby, BS Gail Kurriger, BS James Martin, PhD Peter J. Roughley, PhD](https://reader034.vdocuments.site/reader034/viewer/2022051401/56812b19550346895d8f0a26/html5/thumbnails/34.jpg)
Kevin B. Jones, MDCharles Searby, BSGail Kurriger, BS
James Martin, PhDPeter J. Roughley, PhD
Jose A. Morcuende, MD, PhDJoseph A. Buckwalter, MD, MS
Val C. Sheffield, MD, PhD
Department ofOrthopaedics and RehabilitationUniversity of IowaHospitals & Clinics
Osteochondromagenesis: Loss of heterozygosity modeled via Cre-mediated inversion
of the second exon of Ext1 in chondrocytes
Connective Tissue Oncology Society
London, UK
Friday, 14 November 2008